Skip to content
The Intraday
Pulse

Briefings

Morning BriefOvernight tape and the setup for the openMid-Morning UpdateWhat changed after the opening bell

Markets

Market DashboardTape, movers, watchlist, and cross-asset contextPre-Market SheetOvernight setup, futures, and early moversGlobal SessionsInternational clocks and index performanceInsider ActivityLatest reported executive transactions

DHR Research

Price ChartTechnical charting and drawing workspaceFundamentals ChartCompare financial metrics across timeCompany OverviewA visual snapshot of company performanceFinancial StatementsPrice, filings, key statistics, and news

Newsletter

Morning Production ReportRanked stories, charts, and newsletter readiness

Financial Statements

Explore

Markets, briefings, and company research

DHR
Pulse

Briefings

MorningMid-Morning

Markets

DashboardPre-MarketGlobalInsiders

DHR Research

ChartFundamentalsOverviewFinancials

Newsletter

Morning Report

Newsletter operations and account tools are available from your profile menu after sign-in.

Danaher Corporation

DHR
$209.26
+$4.50 (2.20%)+2.20%
Pre-Market

Danaher names Julie Sawyer Montgomery president and CEO, succeeding Rainer Blair effective Oct. 1, 2026

Loading chart...
IndexN/A
Market Cap147.11B
Enterprise Value175.72B
Income$3.61B
Sales$24.57B
Employees61,000
P/E26.22
P/S6.59
P/B3.08
P/C30.78
EV/EBITDA25.30
EV/Sales24.23
EPS (ttm)7.98
Earnings2025-10-21
Gross Margin58.20%
Oper. Margin20.08%
Profit Margin9.35%
Volume3.06M
Shs Outstand0.70B
Change2.20%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTD2.43%
Perf Year-0.99%
Perf 3Y-3.16%
Perf 5Y12.76%
Perf 10Y310.35%
IPO1978-12-29
Income Statement by fiscal year, newest to oldest
MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Revenue$24.57B$23.88B$23.89B$26.64B$29.45B$22.28B$17.91B$17.05B
Cost of Revenue$9.60B$9.67B$9.86B$10.46B$11.50B$9.81B$7.93B$7.54B
Gross Profit$14.97B$14.21B$14.03B$16.19B$17.95B$12.47B$9.98B$9.51B
Gross Margin60.93%59.50%58.74%60.76%60.95%55.98%55.74%55.75%
Operating Expenses$9.83B$9.02B$8.76B$8.65B$9.90B$8.16B$6.62B$6.44B
Operating Income$5.14B$5.18B$5.28B$7.54B$8.05B$4.31B$3.36B$3.07B
Operating Margin20.91%21.71%22.10%28.29%27.33%19.35%18.77%18.01%
Net Income$3.61B$3.90B$4.76B$7.21B$6.43B$3.65B$2.56B$2.65B
Net Margin14.71%16.33%19.94%27.06%21.84%16.36%14.28%15.55%
EPS (Basic)$5.07$5.33$6.44$9.80$8.77$4.97$3.48$3.78
EBITDAN/A$7.28B$7.50B$9.48B$10.01B$6.54B$4.60B$4.28B
Stock Option Compensation ExpenseN/A$288.00M$306.00M$295.00M$184.00M$187.00M$158.80M$151.40M
Price To Earnings RatioN/A43.0435.7623.6632.4038.1438.0424.16
Price To Sales RatioN/AN/AN/AN/AN/AN/AN/AN/A
Shares OutstandingN/AN/AN/AN/AN/AN/AN/AN/A
Market CapitalizationN/A$167.80B$170.38B$170.59B$208.40B$139.06B$97.27B$64.04B
Balance Sheet by fiscal year, newest to oldest
MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Cash & Short Term InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Short Term ReceivablesN/AN/AN/AN/AN/AN/AN/AN/A
InventoriesN/AN/AN/AN/AN/AN/AN/AN/A
Other Current AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Total Current AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Net Property, Plant & EquipmentN/AN/AN/AN/AN/AN/AN/AN/A
Total Investments and AdvancesN/AN/AN/AN/AN/AN/AN/AN/A
Long-Term Note ReceivableN/AN/AN/AN/AN/AN/AN/AN/A
Intangible AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Deferred Tax AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Other AssetsN/AN/AN/AN/AN/AN/AN/AN/A
Total Assets$83.46B$77.54B$84.49B$84.35B$83.18B$76.16B$62.08B$47.83B
Short Term Debt Incl. Current Port. of LT DebtN/AN/AN/AN/AN/AN/AN/AN/A
Accounts PayableN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax PayableN/AN/AN/AN/AN/AN/AN/AN/A
Other Current LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Total Current LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Provision for Risks ChargesN/AN/AN/AN/AN/AN/AN/AN/A
Deferred Tax LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Other LiabilitiesN/AN/AN/AN/AN/AN/AN/AN/A
Total Liabilities$30.93B$27.99B$31.00B$34.26B$38.01B$36.38B$31.80B$19.61B
Non-Equity ReservesN/AN/AN/AN/AN/AN/AN/AN/A
Preferred Stock - Carrying ValueN/AN/AN/AN/AN/AN/AN/AN/A
Common EquityN/AN/AN/AN/AN/AN/AN/AN/A
Total Shareholders Equity$52.53B$49.54B$53.49B$50.08B$45.17B$39.77B$30.27B$28.21B
Accumulated Minority InterestN/AN/AN/AN/AN/AN/AN/AN/A
Total Equity$52.53B$49.54B$53.49B$50.08B$45.17B$39.77B$30.27B$28.21B
Total Liabilities & Stockholders Equity$83.46B$77.54B$84.49B$84.35B$83.18B$76.16B$62.08B$47.83B
Book Value Per ShareN/A$67.78$72.63$69.08$63.22$56.33$42.35$40.29
Tangible Book Value Per ShareN/A$-13.02$-12.04$-9.66$-26.38$-23.97$-3.05$-6.62
Full-Time EmployeesN/AN/AN/AN/AN/AN/AN/AN/A
Price to Book RatioN/AN/AN/AN/AN/AN/AN/AN/A
Return on AssetsN/A5.03%5.64%8.55%7.73%4.79%4.12%5.54%
Return on EquityN/A7.87%8.91%14.39%14.24%9.17%8.45%9.40%
Return on Invested CapitalN/A6.09%5.66%8.70%8.94%5.07%4.30%5.79%
Quick RatioN/A1.051.371.561.091.554.861.13
Current RatioN/A1.401.681.891.431.865.191.47
Cash Flow by fiscal year, newest to oldest
MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Net Income$3.61B$3.90B$4.76B$7.21B$6.43B$3.65B$2.56B$2.65B
DepreciationN/A$2.35B$2.17B$2.13B$2.17B$1.77B$1.19B$1.18B
Other Funds (Non Cash)N/AN/AN/AN/AN/AN/AN/AN/A
Funds from OperationsN/AN/AN/AN/AN/AN/AN/AN/A
Extraordinary ItemN/AN/AN/AN/AN/AN/AN/AN/A
Changes in Working CapitalN/AN/AN/AN/AN/AN/AN/AN/A
Income Taxes PayableN/AN/AN/AN/AN/AN/AN/AN/A
Cash from Operating Activities$6.42B$6.69B$7.16B$8.52B$8.36B$6.21B$3.95B$4.02B
Capital ExpendituresN/A$1.39B$1.38B$1.15B$1.29B$791.00M$635.50M$584.00M
Net Assets From AcquisitionsN/AN/AN/AN/AN/AN/AN/AN/A
Sale of Fixed Assets and BusinessesN/AN/AN/AN/AN/AN/AN/AN/A
Purchase or Sale of InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Purchase of InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Sale Or Maturity of InvestmentsN/AN/AN/AN/AN/AN/AN/AN/A
Other UsesN/AN/AN/AN/AN/AN/AN/AN/A
Other SourcesN/AN/AN/AN/AN/AN/AN/AN/A
Cash from Investing ActivitiesN/AN/AN/AN/AN/AN/AN/AN/A
Cash Dividends PaidN/A$768.00M$821.00M$818.00M$742.00M$615.00M$526.70M$433.40M
Change in Capital StockN/AN/AN/AN/AN/AN/AN/AN/A
Repurchase of Common Pref StockN/A$5.98B$0.00$0.00$0.00$0.00$0.00$0.00
Sale of Common Pref StockN/AN/AN/AN/AN/AN/AN/AN/A
Proceeds from Stock OptionsN/AN/AN/AN/AN/AN/AN/AN/A
Issuance or Reduction of Debt, NetN/AN/AN/AN/AN/AN/AN/AN/A
Change in Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Issuance of Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Reduction of Long Term DebtN/AN/AN/AN/AN/AN/AN/AN/A
Net Financing Active Other Cash FlowN/AN/AN/AN/AN/AN/AN/AN/A
Other Financing Activities UsesN/AN/AN/AN/AN/AN/AN/AN/A
Cash from Financing ActivitiesN/AN/AN/AN/AN/AN/AN/AN/A
Exchange Rate EffectN/AN/AN/AN/AN/AN/AN/AN/A
Net Change in CashN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash FlowN/A$5.30B$5.78B$7.37B$7.06B$5.42B$3.32B$3.44B
Preferred Dividends (Cash Flow)N/AN/AN/AN/AN/AN/AN/AN/A
Price to Free Cash FlowN/AN/AN/AN/AN/AN/AN/AN/A

Company coverage

Latest news

20 stories
Aug 6 · 9:10PMDiamond Hill Small-Mid Cap Fund Q2 2026 Portfolio Reviewseekingalpha.com ↗Aug 3 · 4:15PMDanaher Appoints Julie Sawyer Montgomery as President and Chief Executive Officerprnewswire.com ↗Aug 1 · 3:55AMDanaher Corporation $DHR Shares Sold by Argent Capital Management LLCdefenseworld.net ↗Jul 30 · 1:20AMAristotle Global Equity Advisory Q2 2026 Portfolio Reviewseekingalpha.com ↗Jul 29 · 3:45AMDanaher Corporation $DHR Stock Holdings Increased by ADAR1 Capital Management LLCdefenseworld.net ↗Jul 27 · 4:24AMCaxton Associates LLP Takes Position in Danaher Corporation $DHRdefenseworld.net ↗Jul 25 · 4:09AMBank of Nova Scotia Sells 3,275 Shares of Danaher Corporation $DHRdefenseworld.net ↗Jul 24 · 10:13AMHere's Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunityfool.com ↗
Show 12 more stories↓
Jul 22 · 10:56AMCan Danaher (DHR) Climb 32.39% to Reach the Level Wall Street Analysts Expect?zacks.com ↗Jul 22 · 5:06AMDon't Quit on Danaher Stock After Horrific Earnings Reactionbarrons.com ↗Jul 22 · 3:45AMDanaher Corporation $DHR Stake Raised by Andra AP fondendefenseworld.net ↗Jul 21 · 12:36PMDanaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Yzacks.com ↗Jul 21 · 12:20PMDanaher Q2 Earnings Review: Nothing Exciting For Me To Buy This Dipseekingalpha.com ↗Jul 21 · 12:03PMDanaher Corporation (DHR) Q2 2026 Earnings Call Transcriptseekingalpha.com ↗Jul 21 · 10:31AMCompared to Estimates, Danaher (DHR) Q2 Earnings: A Look at Key Metricszacks.com ↗Jul 21 · 10:07AMDanaher Q2 Earnings Call Highlightsmarketbeat.com ↗Jul 21 · 9:06AMDanaher Plummets After One Segment Comes In 'Surprisingly Soft'investors.com ↗Jul 21 · 8:50AM5 Things to Know Before the Stock Market Opens on Tuesdayinvestopedia.com ↗Jul 21 · 8:39AMDanaher's revenue outlook cut, biotech miss overshadow profit forecast raisereuters.com ↗Jul 21 · 8:16AMDanaher (DHR) Q2 Earnings and Revenues Top Estimateszacks.com ↗

Insider Trading

View All
Insider
Type
Shares
Price
Value
Date
RALES STEVEN M
Award
500.0K
—
—
Aug 4, 26
RALES MITCHELL P
Award
1.0M
$194.78
$194.8M
Aug 4, 26
Bouda Christopher
Award
12.3K
$194.78
$2.4M
Aug 4, 26
Sawyer Montgomery Julie A
Award
245.7K
$194.78
$47.9M
Aug 4, 26
Leiken Jonathan
Award
92.1K
$194.78
$17.9M
Aug 4, 26

Company

CEO: Rainer BlairEmployees: 59000www.danaher.com
About the company↓

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Discover more

You may be interested in
JPM

JPMorgan Chase & Co

$359.79

↑ 0.63%
INTC

Intel Corp

$97.52

↓ 4.06%
MSFT

Microsoft Corp

$506.06

↑ 1.21%
TSLA

Tesla Inc

$330.88

↑ 0.70%
ORCL

Oracle Corp

$151.04

↑ 2.73%
AMD

Advanced Micro Devices

$469.56

↓ 2.86%
META

Meta Platforms Inc

$594.92

↑ 0.48%
NFLX

Netflix Inc

$76.29

↑ 2.90%
CRM

Salesforce Inc

$197.51

↑ 2.47%
DIS

Walt Disney Co

$103.19

↓ 1.63%
BAC

Bank of America Corp

$63.86

↑ 1.09%
IBM

IBM Corp

$236.31

↓ 0.41%
The Intraday

© 2026 The Intraday. All rights reserved.

Market data may be delayedFor informational purposes onlyFMP · Massive · SEC

Why it moved over time

Catalyst history

1 entry
Jul 29, 2026
Earnings+0.00%

Shares slid after Danaher beat Q2 and raised full-year EPS, as investors focused on the boost coming mainly from the Masimo acquisition and timing-related weakness in biotech consumables shipments.

Key fact: Danaher beat Q2 and raised full-year EPS, but said most of the guidance increase ($0.07–$0.08) comes from the Masimo acquisition while biotech consumables growth was reduced due to shipment timing shifts.

The Motley Fool: Here's Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity↗